Röder C - Search Results

1

Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis.

Bolik J, Krause F, Stevanovic M, Gandraß M, Thomsen I, Schacht SS, Rieser E, Müller M, Schumacher N, Fritsch J, Wichert R, Galun E, Bergmann J, Röder C, Schafmayer C, Egberts JH, Becker-Pauly C, Saftig P, Lucius R, Schneider-Brachert W, Barikbin R, Adam D, Voss M, Hitzl W, Krüger A, Strilic B, Sagi I, Walczak H, Rose-John S, Schmidt-Arras D. Bolik J, et al. Among authors: roder c. J Exp Med. 2022 Jan 3;219(1):e20201039. doi: 10.1084/jem.20201039. Epub 2021 Dec 17. J Exp Med. 2022. PMID: 34919140 Free PMC article.

2

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Among authors: roder c. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

3

TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma.

Trauzold A, Siegmund D, Schniewind B, Sipos B, Egberts J, Zorenkov D, Emme D, Röder C, Kalthoff H, Wajant H. Trauzold A, et al. Among authors: roder c. Oncogene. 2006 Nov 30;25(56):7434-9. doi: 10.1038/sj.onc.1209719. Epub 2006 Jun 5. Oncogene. 2006. PMID: 16751802

4

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).

Arlt A, Bauer I, Schafmayer C, Tepel J, Müerköster SS, Brosch M, Röder C, Kalthoff H, Hampe J, Moyer MP, Fölsch UR, Schäfer H. Arlt A, et al. Among authors: roder c. Oncogene. 2009 Nov 12;28(45):3983-96. doi: 10.1038/onc.2009.264. Epub 2009 Sep 7. Oncogene. 2009. PMID: 19734940

5

TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.

Lemke J, Noack A, Adam D, Tchikov V, Bertsch U, Röder C, Schütze S, Wajant H, Kalthoff H, Trauzold A. Lemke J, et al. Among authors: roder c. J Mol Med (Berl). 2010 Jul;88(7):729-40. doi: 10.1007/s00109-010-0619-0. Epub 2010 Mar 31. J Mol Med (Berl). 2010. PMID: 20354842

6

Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.

Hinz S, Bockhorst J, Röder C, Egberts JH, Schafmayer C, Küchler T, Becker T, Kalthoff H. Hinz S, et al. Among authors: roder c. Ann Surg Oncol. 2012 Aug;19(8):2539-46. doi: 10.1245/s10434-012-2291-9. Epub 2012 Mar 7. Ann Surg Oncol. 2012. PMID: 22395998

7

Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.

Haselmann V, Kurz A, Bertsch U, Hübner S, Olempska-Müller M, Fritsch J, Häsler R, Pickl A, Fritsche H, Annewanter F, Engler C, Fleig B, Bernt A, Röder C, Schmidt H, Gelhaus C, Hauser C, Egberts JH, Heneweer C, Rohde AM, Böger C, Knippschild U, Röcken C, Adam D, Walczak H, Schütze S, Janssen O, Wulczyn FG, Wajant H, Kalthoff H, Trauzold A. Haselmann V, et al. Among authors: roder c. Gastroenterology. 2014 Jan;146(1):278-90. doi: 10.1053/j.gastro.2013.10.009. Epub 2013 Oct 9. Gastroenterology. 2014. PMID: 24120475

8

TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells.

Voigt S, Philipp S, Davarnia P, Winoto-Morbach S, Röder C, Arenz C, Trauzold A, Kabelitz D, Schütze S, Kalthoff H, Adam D. Voigt S, et al. Among authors: roder c. BMC Cancer. 2014 Feb 7;14:74. doi: 10.1186/1471-2407-14-74. BMC Cancer. 2014. PMID: 24507727 Free PMC article.

9

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer.

Hinz S, Röder C, Tepel J, Hendricks A, Schafmayer C, Becker T, Kalthoff H. Hinz S, et al. Among authors: roder c. BMC Cancer. 2015 Dec 16;15:953. doi: 10.1186/s12885-015-1989-z. BMC Cancer. 2015. PMID: 26674974 Free PMC article.

10

Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.

Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T, Röder C. Hinz S, et al. Among authors: roder c. BMC Cancer. 2017 Jan 13;17(1):53. doi: 10.1186/s12885-016-3035-1. BMC Cancer. 2017. PMID: 28086834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page